Analysts have set 12-month price targets for Teradyne, revealing an average target of $126.0, a high estimate of $200.00, and ...
In the last three months, 8 analysts have published ratings on Xylem (NYSE: XYL ), offering a diverse range of perspectives from bullish to bearish.
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $41.17, a high estimate of $46.00, and a low estimate of $38.00. A 3.52% drop is evident in the ...
Throughout the last three months, 11 analysts have evaluated PBF Energy (NYSE: PBF ), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their ...
Analysts have recently evaluated Eaton Corp and provided 12-month price targets. The average target is $408.82, accompanied ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $348.0, a high estimate of $378.00, and a low estimate of $297.00. This current average reflects ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $142.31, a high estimate of $152.00, and a low estimate of $135.00. Observing a ...
Analysts' ratings for MKS (NASDAQ: MKSI) over the last quarter vary from bullish to bearish, as provided by 5 analysts. The table below summarizes their recent ratings, showcasing the evolving ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $33.12, with a high estimate of $50.00 and a low estimate of $28.00. Surpassing the previous ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $12.0, along with a high estimate of $13.00 and a low estimate of $11.50. Marking an ...
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...
Levi Strauss raised its fiscal year 2025 adjusted EPS guidance to between $1.27 and $1.32, versus the $1.31 analyst estimate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results